|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-11-24
|
|
pubmed:abstractText |
Advanced mucinous epithelial ovarian carcinoma (mEOC) has been associated with a worse prognosis than the more common serous epithelial ovarian carcinomas (sEOC), but it remains unclear whether this observation reflects a more aggressive clinical presentation and/or chemoresistance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1569-8041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2377-81
|
|
pubmed:meshHeading |
pubmed-meshheading:20494964-Adenocarcinoma, Mucinous,
pubmed-meshheading:20494964-Adult,
pubmed-meshheading:20494964-Aged,
pubmed-meshheading:20494964-Aged, 80 and over,
pubmed-meshheading:20494964-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20494964-Clinical Trials as Topic,
pubmed-meshheading:20494964-Cystadenocarcinoma, Mucinous,
pubmed-meshheading:20494964-Databases, Factual,
pubmed-meshheading:20494964-Disease Progression,
pubmed-meshheading:20494964-Female,
pubmed-meshheading:20494964-Humans,
pubmed-meshheading:20494964-Middle Aged,
pubmed-meshheading:20494964-Ovarian Neoplasms,
pubmed-meshheading:20494964-Paclitaxel,
pubmed-meshheading:20494964-Platinum,
pubmed-meshheading:20494964-Retrospective Studies,
pubmed-meshheading:20494964-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience.
|
|
pubmed:affiliation |
Université Paris-Descartes, Hôtel-Dieu, France. jerome.alexandre@htd.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
